Pharmaceutical circulation industry reshuffle will soon be eliminated or thousands of Companies incubus

The pharmaceutical distribution industry reshuffle soon tens of thousands of companies or eliminated by the newspaper reporter Zhu Ping Beijing reported review on the current situation, China’s 1.3 Exit 1 million million wholesale enterprises, the remaining 3000 may be the ideal situation. Recently, the CPC Central Committee and the State Council issued the "healthy China 2030" program outline (hereinafter referred to as the "Outline"). Which pointed out in the pharmaceutical industry, to promote the transformation and upgrading of the pharmaceutical circulation industry, improve the flow of market concentration, the formation of a large number of multinational pharmaceutical distribution companies. Up to now, the domestic medical circulation enterprises have 1.3, but the true compliance of less than three thousand. In October 29th, the eighth session of the China pharmaceutical entrepreneur conference and the 2016 pharmaceutical industry innovation forum, CFDA (State Food and Drug Administration) deputy director Wu Zhen to the twenty-first Century economic report reporter pointed out that China’s 80% pharmaceutical wholesale volume concentrated in the top 100 enterprises, in accordance with the rules of market economy, some of the wholesale enterprise is not live down. But the failure of the market economy in the field of pharmaceutical wholesale, not a winner, liezhe Amoy off. Wu Zhen said that the field of circulation regulation to solve the circulation problem, the launch of the two vote, against the votes must be anchored, the whole process of reform, strengthen supervision, including the use of units of the rational use of drugs. According to incomplete statistics, since 2016, there are more than and 200 pharmaceutical commercial enterprises, "drug management quality management certification" (GSP) was recovered, or the drug business license revoked. Another industry insiders pointed out that, after rectification, a large number of non-compliance of the enterprise will be eliminated, will improve the concentration of the circulation market. "13th Five-Year" planning also pointed out that in the "13th Five-Year" period, the country will have a super large pharmaceutical enterprise group and a large number of national and regional large-scale drug circulation enterprises, and through the National SME share transfer system listed drug circulation enterprises financing will be significantly increased, the drug circulation industry concentration will be further improved. The pharmaceutical distribution industry face the challenge of the "Outline" pointed out that the development of drugs and medical devices service circulation enterprises to extend the supply chain, the formation of a new modern circulation system; standardize medical e-commerce, rich medicine circulation channel and mode of development; to promote the application of modern logistics management and technology, improve the modern circulation network of Chinese herbal medicines and the implementation of traceability system; medical institutions, drug procurement subject status, to encourage joint procurement; the construction of modern pharmaceutical distribution network throughout the urban and rural areas, improve the ability of drug supply security base and remote areas etc.. In the industry view, according to the outline shows that the status of the pharmaceutical distribution industry will be strengthened, but also face greater challenges, survival will be the biggest problem of the majority of circulation enterprises. It requires the scale of drug circulation enterprises, the industry focused on the monopoly, the diversification of service capabilities, supply chain management, intelligent feedback, cost control of international class, and the formation of world-class giant enterprise. In fact, CFDA is also in the pharmaceutical industry to carry out the relevant rectification, in May issued a special rectification notice on the field of circulation. July, the State Planning Commission, the national development and Reform Commission, Ministry of finance,.相关的主题文章:

« »

Comments closed.